Koru Pharma Co., Ltd.

Private

SeoulHealthcare & Life Scienceshttps://korupharma.com/

Last Round

Private Equity

May 6, 2026

Est. Valuation

$100M

Company Overview

Koru Pharma Co., Ltd. is a biopharmaceutical company that develops and manufactures medical aesthetic products for anti-aging and skin rejuvenation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical aestheticsdermal fillershyaluronic acid fillersskin boostersthread liftsmesotherapynon-surgical aestheticscollagen stimulatorskin rejuvenationK-beautyPLLA stimulatorfacial contouringbiorevitalizationGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Koru Pharma Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Koru Pharma Co., Ltd. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Koru Pharma Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Equity	May 6, 2026
Secondary	Jan 10, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

정수헌

Chief Financial Officer

Executive Team

Koru Pharma Co., Ltd. Investors

Notable investors and investment history

Koru Pharma Co., Ltd. investors
Investor	Rounds
DSC Investment	Secondary
KB Investment	Secondary
LYFE Capital	Private Equity
IMM Investment	Secondary, Private Equity

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 1, 2025
Monthly visitors increased 73% MoM.
Apr 13, 2025
Monthly visitors increased 62% MoM, reaching 10.7K.

View all signals

Koru Pharma Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Koru Pharma Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Koru Pharma Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range64

Year Founded2016

Last FundingMay 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.